2014 was the last time BCI executed a research on Dutch innovation campuses and science parks, shortly after the launch of Novio Tech Campus. Since then, a lot has changed in the Dutch campus environment. In their update, BCI is stating that Novio Tech Campus is the third largest innovationcampus. Something to be proud of.
Xenikos B.V. is a clinical-stage biopharmaceutical company, developing innovative new immunotherapies, based on conjugated antibodies, designed to improve patient health and quality of life. Currently they are developing a novel therapy for treating acute graft-versus-host disease (aGVHD). “We are extremely pleased to have the support of these top-tier investors not just in terms of financing